Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Medicare Card Rule Issued By CMS; Rx Discounts Will Be Published

  • News

Executive Summary

The Medicare drug discount card program will provide unprecedented public access to actual market prices for pharmaceuticals

You may also be interested in...



Rite Aid Eyes Eckerd Customers During Transition; Profits Recovering

Rite Aid believes its new drug distribution contract with McKesson will bolster the chain's turnaround heading into fiscal 2005

Rite Aid Eyes Eckerd Customers During Transition; Profits Recovering

Rite Aid believes its new drug distribution contract with McKesson will bolster the chain's turnaround heading into fiscal 2005

AARP Will Continue Pricing Dialogue With Manufacturers; Website Planned

AARP will launch its own pharmaceutical price comparison website in conjunction with the rollout of the Medicare-endorsed discount card program

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios

FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says

New EU Filings

See All
UsernamePublicRestriction

Register

PS042990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By